Screener / SEC EDGAR /CIK 0000818686 /10-K filed Feb 3, 2026, compared with Feb 5, 2025 /Numbers from the XBRL of the 10-Ks
NYSE Health care · Pharmaceuticals

Teva Pharmaceutical Industries Ltd TEVA

Compare with peers Embed
Planned sales, announced before they happen

3 trading plans running, 45 Form 144 notices for $127.3M

10-Q, 10-K and Form 144

What TEVA's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Plans adopted or ended

Trading plans · XBRL, 10-Q and 10-K

From Aug 4, 2026 to Jun 5, 2027. The thin line is today; a filled bar is a plan still running, a paler one has ended or expired.

InsiderWhatDateReported in
Dr. Eric Hughes
EVP, Global R&D and Chief Medical Officer
Adopted 10b5-1 plan Sep 1, 2026 10-Q Nov 3, 2026
Christine Fox
EVP, U.S. Commercial
Adopted 10b5-1 plan Aug 4, 2026 10-Q Nov 3, 2026
Matthew Shields
EVP, Teva Global Operations
Adopted 10b5-1 plan Aug 4, 2026 10-Q Nov 3, 2026

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since May 10, 2023.

Notices of planned sales

Form 144 · Form 144 XML, SEC

What the sellers expected to sell on the Form 144 notices filed each month (the value on the notice).

FiledSellerSharesValue
Nov 12, 2026 Sabag Mark
Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL
44,710 $2.0M
Nov 12, 2026 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
20,003 $856K
Nov 10, 2026 Francis Richard D.
Officer
250,000 $10.7M
Nov 9, 2026 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
25,000 $1.1M
Nov 5, 2026 Sabag Mark
Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL
46,000 $1.9M
Nov 4, 2026 Bergwerk Dov
Senior VP General Counsel Corporate Secretary
26,260 $1.1M
Sep 21, 2026 Savage Brian
Officer, CHIEF LEGAL OFFICER
7,028 $273K
Sep 18, 2026 Bridger Management, LLC (1)
Shareholder
367,600 $14.4M
Aug 17, 2026 Lippman Evan
Officer, EVP BUSINESS DEVELOPMENT
18,600 $680K
Aug 3, 2026 Hughes Eric A
Executive VP Global R&D and Chief Med Officer
25,578 $892K
Aug 3, 2026 Jover Placid
Executive VP, Chief HR Officer
12,827 $447K
Jun 18, 2026 Shields Matthew
Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS
9,989 $322K
Jun 11, 2026 Kalif Eliyahu Sharon
Officer, EVP CHIEF FINANCIAL OFFICER
106,563 $3.6M
Jun 5, 2026 Francis Richard D
Officer, PRESIDENT AND CEO
6,153 $211K
Jun 3, 2026 Shields Matthew
Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS
16,195 $532K
May 14, 2026 Lippman Evan
Officer, EXECUTIVE VP BUSINESS DEVELOPMENT
41,658 $1.5M
May 14, 2026 Kalif Eliyahu Sharon
Officer, EVP CHIEF FINANCIAL OFFICER
153,251 $5.5M
May 5, 2026 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
30,000 $1.1M
May 4, 2026 Sabag Mark
Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL
144,180 $5.0M
Apr 30, 2026 Christine Fox
Officer
21,258 $751K
Mar 17, 2026 Sabag Mark
Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL
62,102 $1.9M
Mar 5, 2026 Shields Matthew
Officer, EXECUTIVE VP TEVA GLOBAL OPERATIONS
17,295 $548K
Mar 5, 2026 Jover Placid
Officer, EXECUTIVE VP CHIEF HUMAN RESOURCES OFFICER
14,150 $448K
Mar 5, 2026 Savage Brian
Officer, INTERIM CHIEF LEGAL OFFICER
1,127 $36K
Mar 5, 2026 Fox Christine
Officer, EVP HEAD OF US COMMERCIAL
7,924 $251K
Mar 5, 2026 Francis Richard D
Officer, PRESIDENT AND CEO
20,025 $634K
Mar 5, 2026 Hughes Eric A
Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER
9,533 $302K
Mar 5, 2026 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
17,295 $548K
Mar 4, 2026 Fox Christine
Officer, EVP HEAD OF US COMMERCIAL
9,908 $322K
Mar 4, 2026 Francis Richard D
Officer, PRESIDENT AND CEO
23,393 $759K
Mar 4, 2026 Hughes Eric A
Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER
11,277 $366K
Mar 4, 2026 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
91,345 $3.0M
Mar 3, 2026 Savage Brian
Officer, EXECUTIVE VP INTERIM CHIEF LEGAL OFFICER
1,274 $41K
Mar 3, 2026 Francis Richard D
Officer, PRESIDENT AND CEO
442,935 $14.3M
Mar 3, 2026 Hughes Eric A
Officer, EXECUTIVE VP GLOBAL R AND D CHIEF MEDICAL OFFICER
80,762 $2.6M
Mar 3, 2026 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
128,985 $4.2M
Feb 26, 2026 Kalif Eliyahu Sharon
Officer, EVP CHIEF FINANCIAL OFFICER
345,810 $11.6M
Feb 18, 2026 Francis Richard D
Officer, PRESIDENT AND CEO
447,778 $15.3M
Feb 18, 2026 Francis Richard D
Officer, PRESIDENT AND CEO
447,778 $448K
Dec 12, 2025 Bridger Management, LLC (1)
Shareholder
150,000 $4.5M
Dec 9, 2025 Sabag Mark
Officer, EXECUTIVE VP INTERNATIONAL MARKETS COMMERCIAL
216,892 $6.2M
Dec 9, 2025 Daniell Richard
Officer, EXECUTIVE VP EUROPEAN COMMERCIAL
115,468 $3.3M
Nov 26, 2025 Bridger Management, LLC (1)
Shareholder
50,000 $1.2M
Nov 20, 2025 Fox Christine
Officer, EVP HEAD OF US COMMERCIAL
28,229 $700K
Nov 14, 2025 Fox Christine
Officer, EVP HEAD OF US COMMERCIAL
30,000 $753K
Show the other 37 notices

From the Form 144 XML filed with the SEC, since Nov 14, 2025. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Sources

Regulation S-K Item 408 in the XBRL of each 10-Q and 10-K (since 2023); the Form 144 XML at the SEC.

Also

Insider trades: the Form 4s for the sales these plans led to.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/TEVA/export.csv") into a cell.

Next:Owners
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.